FDAFDA · Food and drugs·Recall number D-168-2013
EXPAREL (bupivacaine liposome injectable suspension), 1.3%, 266 mg/20 mL (13.3 mg/mL) single use vials, INVESTIGATIONAL USE. For Infiltration Only. Not for any other route of administration. Manufactured by Paelra Pharmaceuticals. Inc., San Diego, California, USA
Published March 6, 2013 · Recall initiated: December 17, 2012
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Subpotent; bupivacaine
What to do
Voluntary: Firm initiated · Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit
Recall details
- Manufacturer
- Pacira Pharmaceuticals, Inc.
- Distributor
- Nationwide distribution: AZ, DC, FL, GA, MA, NJ, NY, OH, and TX.
- Lot
- Lot #11-2005 Control #23542 Manufacture Date: 05Dec11 2011-L-009
- Risk classification
- Class II
- Area (FDA)
- drug
- Country
- United States
Sell products like this?
Recalert watches your whole catalog for recalls like this one, automatically.